Acquiring Company
Servier Pharmaceuticals
Acquired Company
Day One Biopharmaceuticals
France
BrisbaneBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Day One Biopharmaceuticals, Inc. has signed a definitive agreement to be acquired by Servier Pharmaceuticals LLC for $21.50 per share in cash. The transaction is expected to benefit shareholders significantly. Further details regarding the shareholder vote and timeline will be provided soon.
Quick answer
Servier Pharmaceuticals is acquiring Day One Biopharmaceuticals, announced March 11, 2026. Servier Pharmaceuticals is based in France.
- How much did Servier Pharmaceuticals pay for Day One Biopharmaceuticals?
- The deal value was not disclosed.
- What does Servier Pharmaceuticals do?
- Servier Pharmaceuticals is an international pharmaceutical company headquartered in France.
- Where are Servier Pharmaceuticals and Day One Biopharmaceuticals based?
- Servier Pharmaceuticals is based in France. Day One Biopharmaceuticals is based in Brisbane, California, United States.
- Who are the decision-makers at Servier Pharmaceuticals?
- Fundz holds 2 contacts at Servier Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- GSK to acquire 35Pharma for HS235 development (February 25, 2026)
- Sanofi completes acquisition of Dynavax Technologies (April 23, 2026)
- Lilly to acquire Centessa for $38/share (April 17, 2026)
- Biogen to acquire Apellis Pharmaceuticals for $5.6B, $5.6B (April 1, 2026)
Who to call at Servier Pharmaceuticals, and when
When Servier Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Servier Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Servier Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Servier Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Servier Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Day One Biopharmaceuticals?
Day One Biopharmaceuticals was acquired by Servier Pharmaceuticals, based in France. The deal was reported on March 11, 2026. Servier Pharmaceuticals is an international pharmaceutical company headquartered in France. It focuses on research and development to provide innovative therapeutic solutions. Servier Pharmaceuticals is privately held and operates in Biotechnology.
When did Servier Pharmaceuticals acquire Day One Biopharmaceuticals?
Servier Pharmaceuticals's acquisition of Day One Biopharmaceuticals was reported on March 11, 2026. Day One Biopharmaceuticals, Inc. has signed a definitive agreement to be acquired by Servier Pharmaceuticals LLC for $21.50 per share in cash. The transaction is expected to benefit shareholders significantly. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Day One Biopharmaceuticals do?
Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It is privately held, operating in Biotechnology, and is based in Brisbane.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.